Profile: KaloBios Pharmaceuticals Inc (KBIO.OQ)

KBIO.OQ on NASDAQ Stock Exchange Global Market

1.70USD
19 Sep 2014
Price Change (% chg)

$0.02 (+1.19%)
Prev Close
$1.68
Open
$1.69
Day's High
$1.73
Day's Low
$1.63
Volume
21,213
Avg. Vol
43,180
52-wk High
$5.77
52-wk Low
$1.36

Search Stocks

KaloBios Pharmaceuticals, Inc., is a United States-based company, which develops protein therapeutics. The Company develops and engineers antibodies and protein therapeutics. Its monoclonal antibodies (mAbs) technology that is being used for reengineering antibodies with products being developed in the areas of infectious disease, autoimmunity, and oncology. Its suite of technologies can also be used for discovery and engineering of other proteins, industrial enzymes and small molecule drugs. It conducts three clinical development programs in leukemia, infectious diseases, and autoimmune diseases.

Company Address

KaloBios Pharmaceuticals Inc

442 LITTLEFIELD AVENUE
SOUTH SAN FRANCISCO   CA   94080
P: +1650.2433100
F: +1302.5313150

Company Web Links

Search Stocks